Make tissues real Poietis (gr. Ποίησις: to make). "The one who makes things real."​ Poietis is a health-tech company specialized in the development of solutions for manufacturing human tissues by 4D Bioprinting. Poietis commercializes its Next Generation Bioprinting (NGB) systems for Cell Therapy & Research Centers and also develops advanced therapies with leading clinicians. 4D Bioprinting, Tissue engineering, Laser, bioprinting, skin, and cell therapy

61 similar entities Type: Startup Activities: deeptech manufacturing biotech Technologies: 3D Printing Synthetic Biology

A project aiming towards a better informed decision-making process on local and regional level. Biomodel4Regions is a bioeconomy project that receives funding from the @HorizonEU Research & Innovation Programme.

40 similar entities Type: Startup Activities: deeptech

T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based therapeutics using our proprietary OpTiMus® platform, based on a fully humanized TCR mouse that provides an almost unlimited source of unique, antigen-specific human TCRs. We combine world-leading expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. biotechnology, research, T cell, biologics, and science

211 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pharmaceutical services company providing testing of drugs and drug candidates in human 3D models of liver and intestine We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com. 3D bioprinting, 3D printing, Drug …

Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

Versatile and easy-to-use 3D bioprinters and bioinks. Bring your work to life. Allevi builds tools to design and engineer with life. Our 3D bioprinters and bioinks are used by leading researchers worldwide to find solutions to humanity's most difficult problems - to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life. Founded in 2014, our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinter to be the most versatile, powerful and easy-to-use bioprinter on the market. Since our humble beginnings, we have grown to …

60 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: 3D Printing Synthetic Biology

Bioceltix is changing the veterinary therapy standards. We develop innovative biopharmaceuticals based on stem cells. Bioceltix is a Wrocław-based and internationally oriented biotechnological company developing innovative, both stem cells and secretome based products, for companion animals. Our flagship technology for manufacturing biopharmaceuticals for veterinary use utilizes the therapeutic potential of allogeneic stem cells (one donor – many recipients). Owning a GMP production facility, we provide single technology for several species, diseases, and routes of administration. Our cutting-edge approach will allow the product to be batch-produced and ready for off-the-shelf sale. The veterinary medicines, based on the immunomodulatory mechanism of action …

231 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The Biosimilar Experts Who we are Formycon AG is a leading, independent developer of high-quality biosimilars, follow-on products of biopharmaceutical medicines. The company focuses on therapies in ophthalmology, immunology, immuno-oncology and other key disease areas, covering almost the entire value chain from technical development through clinical trials to approval by the regulatory authorities. For commercialization of its biosimilars, Formycon relies on strong, well-trusted and long-term partnerships worldwide. About Biosimilars: Since their introduction in the 1980s, biopharmaceutical drugs have revolutionized the treatment of serious and chronic diseases. By 2032, many of these drugs will lose their patent protection – including 45 …

85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advancing Cancer Treatment Breakthroughs Carcinotech provides comprehensive solid tumor research services to advance drug development and enhance personalized therapy decisions. At the heart of its offerings is the proprietary Carcino3DTM bioprinting technology, which creates assay-ready, 3D tumors derived from patient biopsies. This innovative, translational approach delivers a predictive in vitro model, generating critical insights into therapeutic efficacy, and treatment optimization. Cancer research, 3D bioprinting , Cancer microenvironment, drug testing, oncology, assay services, oncology pre-clinical services, solid tumours, solid tumors, tumour microenvironment, tumor microenvironment, early phase drug development, and early drug discovery

274 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Your safety passport for cosmetic ingredients & drug candidates Your partner for toxicological risk assessment requests Using our digital solutions increases the product safety and reduces the product development cost up by 30%. Insight Biosolutions (IBS) with his expert network has developed specialized platforms for in vitro and in silico services. IBS develops digital tools and services for the cosmetics and pharmaceutical industries. Computational Toxicology, in vitro toxicology , Safety assessment, Drug Discovery, Molecular Modeling, Computational Chemistry, CPSR, Pre Clinical screening, ADME, and PBPK

107 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully …

151 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare

423 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

Laboratory for the Bioengineering of Tissues (Mixed Research Unit: Inserm and Bordeaux University) The BioTis laboratory (Laboratoire de Bioingénierie Tissulaire – Laboratory for the Bioengineering of Tissues) is a “Mixed Research Unit” (#1026) that is comprised of personnel from the INSERM, the French national institute of health and medical research), and from the University of Bordeaux. The Unit is located on the 5th floor of the new Bordeaux Biologie Santé (BBS) building at the University of Bordeaux medical campus. BioTis has around 65 members including full time researchers, junior and senior professors in medicine/medical sciences, technical and support staff, post-doc …

70 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents …

87 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Exploring together! We support biopharmaceutical research with translational preclinical models. CYNBIOSE is France-based non-clinical research organization. Preclinical CRO, Pharmacokinetics, POC, Efficacy, Immunotherapies, Drug, Early tox, CNS, Infectious diseases, Respiratory diseases, Non clinical, CRO, PK, PD, and TK

165 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Leading biotechnology company who supports scientists worldwide with high-end human cell culture products and services. At PromoCell, we help scientists do better research with a world-class portfolio of human primary, stem and blood cells as well as optimized cell culture media. With over 35 years of expertise, we are recognized globally for supplying scientists with the tools and support they need to do groundbreaking research. All our products comply with European biomedical conventions, ensuring human rights and donor privacy are always protected. Our ISO certifications demonstrate our absolute commitment to quality and our EXCiPACTTM GMP certification enables us to produce …

141 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

For over 30 years we have been a reference in the production of vaccines and veterinary products. Proud to be 100% Brazilian. Labovet is a pharmaceutical company that offers medicines and vaccines for small, medium and large animals. For over 30 years, our focus has been on animal health, through products with high quality standards and constant investments in research and modernization of our factory. We operate throughout Brazil with distribution centers in strategic points across the country, in order to have the best delivery conditions and guarantee the good packaging of our products. Biologicals, Therapeutics, Hygiene, Veterinary Medicines, and …

108 similar entities Type: SMB Activities: pettech deeptech biotech Technologies: Synthetic Biology

Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI

267 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology

Tiss’You – Regenerative Company – researches and develops medical devices to upgrade your body’s natural healing ability Tiss'You - Regenerative Company - researches and develops medical devices for regenerative medicine to help doctors and patients with innovative therapeutical solutions. Tiss'You is also a production facility of 850 sqm of which 240 sqm are clean rooms. We have next-generation equipments for R&D, production and quality control; 2 patents, 4 tissue substitutes and 2 point-of-care cell therapy devices. medicina rigenerativa, ricerca e sviluppo, clinica privata, prevenzione, innovazione, ortopedia, chirurgia vascolare, wound healing, lipocell, monocytes, integratori alimentari, regenerative medicine, food supplements, biomaterials, medical …

128 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Your partner in testing solutions Abich - Lifeanalytics is the Competence Center dedicated to Cosmetics and Medical Devices. Abich laboratories develops new and updated methods on biotechnology field to verify safety and efficacy of cosmetics and medical devices. The Clinical Trials Division also performs tests on healthy volunteers under the supervision of specialised personnel and in compliance with the standards for the sustainability of cosmetic claims and medical devices. Lifeanalytics, part of the CERBA Healthcare Group, was born from the union of 60 Italian companies that have over forty years of experience in analytical services of chemistry, microbiology and biology …

79 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

We accompany companies with a complete service of Preclinical Trials and Clinical Trials of safety and efficacy GOYA INNOVA is a Spanish laboratory with 50 years of experience, specialized in preclinical and clinical evaluations of safety and efficacy for cosmetic, health products and food supplements.⁣ We manage 55,000 samples annually, and with our partners, we offer a comprehensive service.⁣ Our differential model of preclinical and clinical research integrates a CRO with its own Medical and Medical-Aesthetic Center.⁣ With more than 40 doctors of different specialties, we can:⁣ • Carry out studies under the highest quality standards⁣ • Optimize costs and …

289 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Rethink and Accelerate Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers. Nostrum Biodiscovery provide advanced technologies in Molecular Modelling, with two areas of focus : therapeutics, e.g. small molecules design, targeted protein degradation, antibodies, immunologics and nucleic acids, and bio-based chemistry as in enzyme engineering. Nostrum Biodiscovery’s customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms. With …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Better Science, Better Health 🧬 The OptiBiotix difference; improving health and wellbeing. OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. OptiBiotix has established a pipeline of …

61 similar entities Type: Startup Activities: healthtech deeptech Technologies: SaaS

The world's go-to partners for infectious disease biomaterials and testing services. We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan. Microbiology, Biotechnology, Quality Control, Molecular Microbiology, Contract Research Organization, Virology, Anti-Infective Drug …

207 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Customized Bioprinting systems and Bioreactors. Creating Life Changing Futures. REGEMAT3D develops customized Bioprinting Systems and Bioreactors - BMAP. We create Living Tissue Technologies. The potential of bioprinting in regenerative medicine and tissue engineering is huge. There are still many problems to be solved and many hypothesis to be tested in order to find solutions to tissue regeneration. Our mission is to develop innovative solutions in the area of bioprinting and regenerative medicine towards the clinical application of this amazing technology, to improve people ́s quality of life. bioprinting, regenerative medicine, biotechnology, and tissue engineering

71 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

Design, Production, and Delivery of Antibodies – Reimagined by AI Genotic utilizes AI for the rapid design and production of customized antibodies for all kinds of targets. Our fully computational, animal-free approach guarantees high quality and delivers solutions within weeks, not years. biotechnology, machine learning, and antibody

247 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: A.I.

Innovative Manufacturing Services (IMFS).

176 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity

512 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

EXPERT EN TESTS & ANALYSES DU MICROBIOME Our R&D center, located in the heart of the Cosmetic Valley in Chartres, focuses on analyzing the compatibility of cosmetic products with the skin. Our microbiology laboratory assists our clients in scientific expertise, marketing communication of claims, and helps R&D scientifically substantiate claims. It stands out for its commitment to innovation, combining industrial and technological expertise to advance knowledge and expertise on the microbiome for cosmetics. Microbiome, Immunologie, IA, Tests et analyses, Dermocosmétique, Cosmétique, Microbiote, Microbiologie, Innovation, Biotech, Startup, Made in France, and Experts

103 similar entities Type: SMB Activities: deeptech cosmetics Technologies: A.I.

Innovative scientific services on efficacy testing for bioactives or formulated products to support healthy aging. OxiProteomics is a CRO French specialized in biomarker assessment providing research services for skin care dermo-cosmetics, medical devices, and dermatology efficacy evaluation. Spined-out from Sorbonne University in 2014, our uniqueness is a specific know-how on non-targeted & targeted proteomics approaches adapted to skin and hair evaluation. We support our clients on molecular target identification, target validation, efficacy testing, mechanistic studies, prediction of responders, and biomarkers discovery. We also propose predictive pre-clinical skin models coupled with spatial proteomics analyses, based on the organ culture of human …

99 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

633 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

From research to patients: safer, smarter, faster. 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidates. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Our Three Pillars are: 1.Safety 2. Efficacy 3. Manufacturing These are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan of execution. We have implemented a human and customer centric organization to provide the best …

124 similar entities Type: Startup Activities: biotech deeptech fintech manufacturing regtech Technologies: Synthetic Biology

🔬 French manufacturer of medical devices based on biopolymer (P4HB) Apha Biomat is part of the Ph Tech group, together with Meccellis Biotech (expert in biologics for Soft Tissue repair). Apha Biomat’s new industrial facility will support Xenopha’s manufacturing operations, alongside with Meccellis. Xenopha is the result of an intensive R&D program aiming at combining Meccellis’ expertise in biologics with a new biopolymer:P4HB. This hybrid combination allows for the design of natural 3D medical devices. Xenopha’s first indication is dedicated to breast reconstruction where a solution to replace silicon is eagerly awaited by patients and surgeons. For any further information, …

119 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusive diseases. Aspect Biosystems is a biotechnology company pioneering the development of a novel category of cellular medicines designed to replace or restore biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders. bioprinting, regenerative medicine, therapeutic development, …

64 similar entities Type: Startup Activities: deeptech biotech Technologies: 3D Printing New Materials Synthetic Biology

Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in …

132 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Innovations from Nature The Austrian Centre of Industrial Biotechnology (acib) replaces conventional industrial processes by new, more ecological and economical methods that are adopted from nature. Therefor acib can rely on 30+ years of experience and a network of 180+ mostly longterm international scientific and corporate partners and 200+ researchers in the multiple disciplines of industrial biotechnology and bioengineering. The acib network meets the needs of of the biotechnological, chemical and pharmaceutical industry and is the preferred partner for competitive research in industrial biotechnology – focused on biocatalysis, enzymes and (pharmaceutical) protein production. acib partners get access to innovative scientific …

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Printed electronics dedicated to health PRINTUP INSTITUTE specializes in the formulation of specific inks and in printing processes. The development of the institute is focused on health applications. It is a new technological model which aims to develop a PRINTED ELECTRONICS FOR HEALTH value chain, from biomolecular design to the supply of medical devices intended for health professionals. Within PRINTUP INSTITUTE: . Biomolecular research and development and the design of printed sensors are carried out in the ITODYS laboratory of 110 people at Paris Cité University, recognized in this sector of bioelectronics. . A PRINTEC technological platform with the provision …

69 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Through its subsidiaries, Mayoly is a family-owned, independent, French pharmaceutical and dermatological laboratory with an international footprint. For more than a century, it has successfully been growing its business with a focus on Gastroenterology and Dermocosmetics. Our French industrial heritage relates to our values ​​of Responsibility, Pragmatism and Caring. We strive passionately and tirelessly to provide patients and people with the best possible healthcare daily, and aim to establish ourselves as a leader in Consumer Healthcare over the coming decades Our know-how applies to several therapeutic areas, such as gastroenterology, rheumatology, ENT, general medicine and general public health. We are …

288 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue

71 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology

Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - …

197 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech

385 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Building a sustainable sector and accelerate the discovery of new treatments tailored to each patient. French consortium to develop new experimental models of cancer in 9 cancer pathologies of interest (Lung, Pancreas, Breast, Liver, Ovary...) 3 major R&D axes: - Developing in vivo models and cell-based assays - Mimicking the human biology by humanizing the tumor microenvironment in mice - Studying the microbiota in cancer patients Oncology, Cancer research, Patient derived Xenograft, Cell lines, Ex vivo assays, Microbiota, Data mining , Translationnal medecine, Humanized mice, Biomarker, Research and Development, In vivo models, Ex vivo models, and Cancer

264 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Microbiome-Driven Skin Health & Personal Care Innovation HelloBiome is a B2B biotech platform specializing in microbiome data collection, clinical research, and AI-driven analytics for consumer health and beauty. We support brands, ingredient suppliers, and manufacturers in translating clinical microbiome data into actionable insights, validated claims, and targeted product development. Our platform combines non-invasive microbiome sampling, large-scale clinical studies, and proprietary AI models to redefine skin, scalp, and body profiling beyond traditional typologies. Trusted by global industry leaders, HelloBiome operates at the intersection of microbiome science, clinical research, and applied AI to build the next generation of data-driven consumer health solutions. …

83 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I.

Reducing the gap between Lab and Clinical Trials with Physiological and Pathological Non-Animal Models Unique R&D platform of donor-derived real human adipose tissue ex vivo models for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research. ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology to develop preclinical models derived from human adipose tissue obtained from patients. These models maintain their native 3D structure, stem cells, functionality, and vascularization over the long term in culture, providing a faithful representation of clinical conditions. They enable the pharmaceutical industry to generate reliable human data in the …

74 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined …

95 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Human primary cells to enhance your research Specialized in cell culture, Abcell-bio has a 10-year background and experience in Stem Cell Research and Development. Abcell-bio team is composed of experts that can advise you for your research projects. Our technical team is trained to produce high-quality products in the fields of hematopoiesis and vascular biology. We can process several cell types extracted from: * Cord Blood: CD34+ cells, CD133+ cells, CD34- cells, MonoNuclear Cells (MNCs), Endothelial Progenitor Cells (EPCs) * Umbilical Cord (Human Umbilical Vein/Arterial Endothelial Cells (HUVEC, HUAEC) We also created Cell Culture Media to match your needs for …

110 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

L'os humain préservé et régénéré BIOBank is a leader providing high-quality bone allografts to surgeons in orthopaedics, maxillofacial, and dental surgery. Our bone grafts are sourced from living donors in France & processed via our perfected Supercrit® technology, providing key advantages to surgeons and patients: - Total viral-inactivation - Maintainance of biomechanical and structural intergrity of the tissue - Availability in various shapes & forms, allowing easy handling during the surgical procedure - High quality bone integration, improving patient recovery BIOBank assure l’ensemble des activités d’une banque de tissus, de la prise en charge des tissus (recueil) à la délivrance …

46 similar entities Type: SMB Activities: healthtech biotech

Tetratherix has developed the first biostealth fluid matrix to disrupt regenerative medicine and targeted drug delivery. [ASX:TTX] Tetratherix has developed a proprietary fluid matrix that is invisible to the body & does not induce any foreign body reaction to evolve regenerative medicine and targeted therapeutic delivery. Tetramatrix is a water based polymer solution that forms an adhesive hydrogel once administered to the body. The product is fully synthetic, biocompatible and resorbable. After a decade of development with meticulous polymer programing, Tetratherix is advancing the world of biopolymers by developing real world applications specific to multiple indications in an effort to …

42 similar entities Type: Startup Activities: biotech Technologies: New Materials

Pioneering Solutions to Understand, Diagnose, and Treat Bone Conditions​ CompagOs is bringing better bone health to all by empowering researchers to transform discoveries into clinical applications, while enabling physicians to match patients with the right treatments and support faster recovery. At the core of our mission are our biologically relevant and reproducible Bon3OIDTM in vitro bone models, developed using state-of-the-art 3D bioprinting. Leveraging this technology, we are currently focused on developing a blood-based assay to detect bone metastases earlier than existing imaging methods, representing a key step toward advancing bone health. Additionally, we provide comprehensive services to academic researchers and …

70 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

We were made for this 53Biologics is a end-to-end biologics CDMO built to keep progress moving. By combining scientific expertise, integrated in-house capabilities and a collaborative way of working, we enable confident decision-making as biologics programs evolve. We support your biologic from early development to commercialization. With USP and DSP development, GMP manufacturing, quality control and fill-finish connected under one roof, we reduce handoffs, protect continuity and help clients grow without disruption. We were made for this. Biopharmaceuticals , CDMO, pDNA, Recombinant Protein, GMP, Drug Development, Microbial Manufacturing, Cell Banking, and GMP Manufacturing

353 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

FIRST-IN-CLASS SKIN TISSUE THERAPEUTICS - late clinical stage TECH-BIO company CUTISS is a late-stage clinical TechBio company and the only one transforming skin surgery and advanced dermatology with revolutionary skin tissue therapeutics. We are developing the first BIO personalized and automated skin tissue therapy for patients requiring skin surgery for a large spectrum of indications- from severe burns to reconstructive and aesthetic procedures. Our lead product denovoSkinTM is a first-in-class, bioengineered, personalized skin tissue therapy designed to improve patient outcomes and redefine the standard of care in skin surgery. Currently in Phase 3 clinical trials in the European Union, it …

59 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Your partner for preclinical research in Osteoarticular diseases, Inflammation, Skin diseases... Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of inflammation, osteoarticular diseases and skin diseases. Thanks to its high expertise, Atlantic Bone Screen evaluates drug candidates, biomaterials (either for orthopedic or dental applications) and ingredients/products for cosmetics and food industry. We provide high-quality services to support the characterization of drug candidates, nutraceuticals, biomaterials,... Located in Nantes, North-West of France and created in 2005, Atlantic Bone Screen puts at your disposal a unique preclinical platform with a …

63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We are your responsive, reliable, and resourceful CDMO Partner. Streamline your biomanufacturing programs with Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage. From early needs like cell line development and strain selection to cGMP manufacturing for …

192 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine

348 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Design · Develop · Deliver 3BarBio offers increased profitability to discovery companies, bulk suppliers, and distributors by addressing the major hurdle to further adoption of biologics by designing innovative packaging to deliver viable microbes to the ag market. With its proprietary LiveMicrobe® Design. Develop. Deliver. process, 3Bar delivers on demand for partners around the world. Manufacturing, Innovative Packaging, Engineering, Supply Chain, and Agricultural Biologicals

47 similar entities Type: Startup Activities: agritech biotech deeptech manufacturing

3D matrices for tissue reconstruction Application to breast reconstruction The MAT(T)ISSE project proposes to create a new bioprosthesis, a class 3 implantable medical device, which aims to help the body restore damaged regions following curative surgical interventions. This tissue restoration is carried out through the autologous collection of fat cells (adipose tissue) re-implanted on a synthetic and resorbable lace-type textile structure. The textile structure has a role of maintenance, assistance in the multiplication of implanted fat cells and revascularization. It is coupled with a bioresorbable and personalized 3D shell which delimits the volume to be reconstructed. Ultimately, the resorbable support …

56 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Ncardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients faster. Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process …

424 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

EV Biotech is a microbial cell factory (MCF) strain development company. EV Biotech distinguishes itself by the use of state-of-the-art computational modelling. Using cutting-edge scientific developments in systems biology we create computational models of bacterial strains to predict most optimal strain modifications, growth media supplementation and scale up optimization in line with the rational design strategy. Fast-feedback loop between strain modellers and engineers increases development speed and efficiency of the MCF strain development pipeline. Preliminary models can be updated and enhanced quickly if needed, due to a close collaboration between a theoretical and experimental departments. EV Biotech creates highly effective …

79 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

#BeyondBoundaries At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment. Over the past 20 years, we’ve earned a track record of real impact: 60+ advanced candidates, 200+ patents filed, 200+ active projects. Over 90% of our customers choose to stay with us – from biotechs racing to clinic to pharma companies that …

271 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Your gastrointestinal research partner. Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract.

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Data Analytics

Create the future of health CELLINK is proud to be part of BICO. BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,900 publications. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm …

60 similar entities Type: SMB Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

Unlocking the next generation of biotech solutions (LON: BSFA). Unlocking the next generation of biotech solutions and financing the development of lab-grown meat, leather, human corneas, and skin substitutes (LON:BSFA). Owns 100% of 3D_BioTissues

59 similar entities Type: Startup Activities: deeptech

Bringing expertise and agility to biotech companies Founded in 2013 and headquartered in Montpellier, France, INITS is a pharmaceutical development and biomanufacturing services company supporting biotech and life sciences companies developing new therapeutic products. With more than 13 years of experience and over 250 clients supported in France and internationally, INITS provides expertise across biologics (cell and gene therapies, extracellular vesicles, antibodies and proteins) as well as small and large molecules. Its team of more than 40 experts supports the full range of pharmaceutical development activities, including CMC development, Regulatory Affairs, Clinical Supply, Quality Assurance and GMP audits. INITS is …

67 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Sterile Solutions, Built Differently. ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow’s medicines. Our sites in Visp and Basel 🇨🇭 support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients. More about us: www.ten23.health Subscribe our newsletter: www.ten23.health/ten23-health-newsletter biopharmaceuticals, pharmaceutical industry, Contract Manufacturing, Sterile Manufacturing, Aseptic Manufacturing, Drug Device Integration, Analytical Development, Analytical Testing, Molecule Selection, Packaging , and Formulation Development

412 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

589 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South …

202 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

BioCryst Pharmaceuticals is a commercial-stage biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, led by the efforts of our team of expert scientists in our Discovery Center of Excellence in Birmingham, Alabama. Our global headquarters is in Durham, North Carolina, we have a regional office in Boston, Massachusetts, and our employees span the globe across sites in multiple countries. We are proud of our culture of engagement and …

409 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Technology development, R&D, Biobased ingredients Activatec develops technologies to produce biobased ingredients from renewable sources. We are specialised in the evaluation, scale-up and commercialisation of processes to produce biotechnological and plant-based ingredients and materials from currently unused and low-value organic sources. Activatec is a B2B Partner that provides support to the industrial biotechnology sector in the form of research services on a contract basis. We are currently working within a number of international partner projects to design, develop and scale-up novel technologies for the production of emerging and high-value bio-based products. biotechnology, research and development, biotech, biobased products, bioproducts, bioingredients, …

133 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Bio sourced materials

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Delivering local-acting immunotherapies to patients ATMP, Gene Therapy, Drug development, Clinical trials, GMP, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, IBD, Cysticfibrosis, SAVI, colitis, Cystic fibrosis, and Inhalation

646 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The logical choice. Microtech was born in 1964 from an idea of ​​the founder Gaetano Papagno. It is based in Naples and specializes in the promotion, sale and distribution of consumer products, reagents and equipment for molecular, cellular, genetics and biochemistry biology in all laboratories of Scientific Research Centres, Universities, C.N.R., Industries, Hospitals and Private individuals. Seriousness, commitment and scrupulousness are the principles that distinguish it, which are recognized by both customers and suppliers. For over 40 years our goal has been to create, in central-southern Italy, a quality organization that contributes, with its products and services, to simplifying the …

167 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The IBBL Institute is a biobank dedicated to supporting biomedical research for the benefit of patients. The IBBL (Integrated BioBank of Luxembourg) Institute is a biobank dedicated to supporting biomedical research for the benefit of patients. The mission of IBBL is to provide high‐quality biospecimens and associated data, foster scientific excellence, catalyse partnerships and support research that translates scientific discoveries into new healthcare solutions. IBBL is an integrated research infrastructure, compliant with international quality standards, offering biobanking services, including the collection, processing, analysis and storage of biological samples and associated data. In addition, IBBL carries out research to optimise biospecimen …

58 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics

Leading the Industry in Animal Model Solutions. Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world. Life Science …

51 similar entities Type: SMB Activities: deeptech biotech

Biotecal is a biotechnology company that researches, develops and promotes innovative marine biomolecules. Biotecal's expertise and unique know-how enable the identification, characterization and commercialization of molecules with very high potential for various sectors such as cosmetics, pharmaceuticals or neutraceuticals. blue biotechnology, microbiology, biodiversity, and polymer production

61 similar entities Type: Startup Activities: biotech deeptech manufacturing

Developing first-in-class solutions for unmet health and personal care needs Results through innovation. We are an innovative biotechnology group with two divisions. Our consumer health arm has commercial products for the personal care market addressing nail, skin, scalp and hair issues. NovaBiotics pharma division has advanced clinical-stage product candidates for medically unmet, life-limiting inflammatory, infectious and respiratory disease. Our highly disruptive solutions to personal care and health needs address significant global markets. biotechnology, biologics, infectious disease, and drug discovery & development

225 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Develop human organ models with true physiological complexity We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling. Organ-on-Chip, Human Cell Biology, Infection, Infectious disease, Toxicity profiling, Immune Cell Interactions, Inflammatory Diseases, Antibody recycling, and Uptake / Transport studies

263 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Our core technology, magnetic 3D bioprinting, works by magnetizing cells and aggregating them with magnetic forces into models that represent native tissue environments. The advantages of this platform over other 3D cell culture and bioprinting platforms are speed, ease, and handling. n3D offers products and services around this technology, with a worldwide distribution network, including an OEM partnership with Greiner Bio-One Cell culture, Assay development, 3D cell culture, Precision medicine, Toxicology, and …

70 similar entities Type: Startup Activities: biotech healthtech deeptech Technologies: 3D Printing Synthetic Biology

Centre d'Etudes Biologiques et Pharmaceutiques OUR MISSION: Provide analytical support for all product development phases (human & veterinary medicines + Medical Device) with: Consulting and expertise Formulation development support Analytical method development and validation Stability studies QC testing Veterinary pre-clinical and clinical studies Analyse pharmaceutique, Pharmaceutical analysis, Contract Research Organization (CRO), Développement analytique, Contrôle qualité pharmaceutique, Quality control (QC), Method development, Analytical method validation, ICH guidelines, ICH Q2 / ICH Q14, Validation analytique, Transfert de méthodes, Biopharmaceuticals, Small molecules, sterile products, Vaccins, Stability studies, Regulatory affairs, GMP compliance, GLP compliance, CCIT (Container Closure Integrity Testing), Extractables & Leachables, Elemental impurities …

135 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

business development mission in Life Sciences IVD Cosmetic finding new customers finding new partners BtoBioInnovation offers outsourced services in Marketing & Business Development in Life Sciences, Biotech, Molecular Diagnostics, Cosmetic, Nutraceutical : - Operational Marketing : representation on Trade shows, congresses, Seminar organisation - E-Marketing: E-mailing Campaign, Google Analytics, webinars - Strategic Business Development: Chinese Market, Trends in oncology, Neurology, Biomarkers, Molecular Diagnostics, coaching for Negociation & Due Diligence, Analysis of Pharma & Biomedical Industries. - Operational Business Development: Identify & qualify new customers, partners, distributors, Sourcing licensing opportunities, Marketing, Business development, Biotech, Life sciences, In vitro diagnostics, Cosmetic, Nutraceutical, …

222 similar entities Type: SMB Activities: martech biotech Technologies: Synthetic Biology

CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization

164 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The cosmetic expertise from the ingredient to the finished product Specialized in the assessment of finished cosmetic products, ingredients and cosmetic raw materials, we perform tolerance and efficacy studies. BIO-HC in-vitro : toxicological and pharmacological tests on cell models (primary cells, cell lines) and tissue models (epidermis, skin reconstructed in vitro). In vitro tests, GLP studies, and OECD tests

76 similar entities Type: SMB Activities: biotech deeptech cosmetics Technologies: Synthetic Biology

We are a worldwide leading manufacturer in cell counting and analysis. Born in Scandinavia, operating globally. ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments. We are experiencing exponential growth, as the company strives towards our goal to be the number one provider in Life Sciences. Designed, manufactured and tested in Denmark, our instruments and consumables are built with quality materials and dedicated expert workmanship. Find us on Glassdoor: https://bit.ly/3pjjzTA Manufacturing Cell Counters, Manufacturing Cell Analyzers, …

433 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

QIMA Life Sciences (formerly Bioalternatives, Synelvia, Newtone Technologies and Monasterium Laboratory) is a Contract Research Organization (CRO) specializing in cellular and molecular pharmacology. We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays. QIMA Life Sciences contributes to the development of in vitro methods, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations. QIMA Life Sciences can assist the health industry with its new strategic choices and helps the marketing and R&D departments to innovate in …

117 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We design and supply artificial tissue environments for cell culture & bioprinting applications. Biogelx is helping people work in translational science, drug discovery and tissue engineering by 'making in vitro cell cultures more in vivo'​. We do this through manufacturing and supplying 3D cell cultures that can be tuned to specific tissues and synthetic bio-inks that are reproducible, scalable, easy to handle and suitable for clinical decision making. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that act as extracellular-matrix environments to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely …

87 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

418 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

BDI biotech provides biotechnological services and solutions in the Cosmetics, Agro, Food and Industrial fields. At BDI biotech we provide biotechnological services and solutions in the Cosmetic and Nutraceutical fields, providing as well LBP production, to bring ideas from bench to reality. We work as an external R&D department specialized in strain and bioprocess development (production, recovery and/or its application), scale-up and regular batches productions. Our Services: 1) Strain Selection & Improvement. Whether it's yeast, fungi, or bacteria, we provide the tools and services to increase byproduct or biomass production. 2) BioProcess Development & Scale-Up: BDI biotech has strong expertise …

159 similar entities Type: Startup Activities: biotech deeptech cosmetics Technologies: Synthetic Biology

Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products …

97 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

582 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

SEQENS In Vitro Diagnostic | Blood fractionation for IVD | Located in Limoges (France), H2B manufactures fractionated blood products for the life sciences and IVD industries. Thanks to over 20 years of experience, the company has developed a considerable expertise in blood fractionation, extraction and purification. H2B offers a wide range of products including BSA and bovine fibrinogen on the one hand, human sera and plasma on the other. Visit our website for more informations and to find the complete listing of products (www.h2b.fr). in vitro diagnostic and blood fractionation

59 similar entities Type: SMB Activities: biotech deeptech

Next Big Innovation Labs® is a Deep Tech Lifesciences platform, developing 3D Bioprinting Technology and Products Next Big Innovations Labs (NBIL) is a startup of enthusiastic individuals on a mission to confront the world’s most challenging problems in the healthcare space. We are a research driven startup working on a novel approach to tackle the current muddle vexing the pharmaceutical, clinical and cosmetic R&D sectors. We feel we can crack these problems only by using the disruptive technology of 3D Bioprinting. At NBIL, we focus to solve the organ availability crisis plaguing the entire globe using 3D Bioprinting; aiming to …

63 similar entities Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology

Next generation chromatography resins Bio-Works was founded in 2006 and is involved in R&D, manufacturing and supply of innovative, leading edge products used to separate proteins and other biomolecules. Our staff is rich in experience within the Swedish Life science industry and are specialized in resins for separation and purification. Bio-Works'​ research, development and production facilities are located in Uppsala, Sweden. We are actively working with sustainable development and our Quality Management System is based on ISO 9001:2015 standards. Bio-Works produces agarose based products with exceptional performance. These are used in academic research laboratories, biopharmaceutical companies, and many more areas. …

109 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule

634 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Accelerating research & development Integrated BioTherapeutics LLC (IBT Bioservices) is a contract research organization (CRO) offering in vitro and in vivo services as well as products to support your biomedical research and development needs. Whether you are a biotech startup or an established pharmaceutical company, IBT serves as your trusted partner, simplifying the development process and accelerating your journey toward bringing innovative biotherapeutics to patients in need. The team of highly skilled scientists, researchers, and industry experts at IBT work collaboratively to deliver exceptional results and accelerate the development process for its clients. By offering comprehensive services and concierge-level support …

76 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

French manufacturer of biologic implants Meccellis Biotech is a company expert in Tissue and Cell Engineering with a diversified offer for multiple surgical specialties. After 7 years of marketing, Meccellis Biotech is now present in 25 countries. The passion and professionalism of its teams have made of Meccellis Biotech, a reference company for the manufacturing of biomaterials. For any further information you may need regarding our range of biologic implants, please feel free to contact us: contact@meccellis.com - Phone number: +33 (0) 5 17 81 07 63 - THE MECCELLIS BIOTECH TEAM Breast reconstruction: CELLIS Breast, General surgery: CELLIS, and …

61 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large …

257 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. …

437 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

making a difference Greiner Bio-One: Innovative solutions for your hospitals, laboratories and research facilities We specialize in the development, production and distribution of high-quality plastic products for laboratories worldwide. As a reliable technology partner, we support hospitals, research institutions, laboratories as well as the diagnostic, pharmaceutical and biotechnology industries with customized solutions. Our focus: ☑ Preanalytics: We are setting new standards in safety and efficiency with innovative collection systems for blood, urine and saliva sampling. Our customized digital solutions (Greiner eHealth Technologies) optimize processes and increase patient safety in laboratories and medical practices. ☑ BioScience: We offer highly specialized products …

481 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

#BeyondBoundaries At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment. Over the past 20 years, we’ve earned a track record of real impact: 60+ advanced candidates, 200+ patents filed, 200+ active projects. Over 90% of our customers choose to stay with us – from biotechs racing to clinic to pharma companies that …

279 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Sustainable Product Innovation & Development Hexislab (www.hexislab.com) uses proprietary technology AI techniques to facilitate the development of breakthrough products for the beauty, skincare, personal care, nutraceuticals, and pharmaceutical industries. We use ground-breaking processes that accurately predict the behaviour of chemicals and ingredients in biological systems. Our technology is helpful for new product research & development, identifying novel ingredients and formulations. We assist customers across all stages of their research and development journeys, helping them reduce costs, overcome bottlenecks, and to find innovative solutions to meet modern consumer demands. Find out more! Please email us at info@hexislab.com Artificial intelligence, Deep learning, …

353 similar entities Type: Startup Activities: deeptech Technologies: A.I. A.I. - Machine Learning